新泽西州 的 非小细胞肺癌 临床试验
新泽西州 有 88 项针对 非小细胞肺癌 的研究正在招募参与者。
新泽西州 的城市
官方研究文本（英文）
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
- The Valley Hospital - Luckow Pavilion, Paramus
- Valley Health System Ridgewood Campus, Ridgewood
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年10月2日 · NCT04267848A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
- Memorial Sloan Kettering Basking Ridge, Basking Ridge
- Memorial Sloan Kettering Monmouth, Middletown
- Memorial Sloan Kettering Bergen, Montvale
招募中2 期
18 岁及以上 · 所有性别 · 更新于 2026年10月2日 · NCT07293247A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
- START New Jersey, East Brunswick
招募中1 期
18 岁及以上 · 所有性别 · 更新于 2026年10月2日 · NCT06270706Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Exelixis Clinical Site #88, East Brunswick
- Exelixis Clinical Site #105, Hackensack
招募中1 期
18 岁及以上 · 所有性别 · 更新于 2026年10月1日 · NCT05176483Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
- Ocean University Medical Center, Brick
- Southern Ocean County Medical Center, Manahawkin
- Jersey Shore Medical Center, Neptune City
- 以及另外 1 项
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年10月1日 · NCT07388524A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
- Astera Cancer Care /ID# 277570, East Brunswick
招募中2/3 期
18 岁及以上 · 所有性别 · 更新于 2026年10月1日 · NCT07155187A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)
- John Theurer Cancer Center at Hackensack University Medical Center ( Site 0152), Hackensack
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年10月1日 · NCT07190248A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
- ALX Center 12, Morristown
招募中1 期
18 岁及以上 · 所有性别 · 更新于 2026年9月30日 · NCT07085091A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer
- START New Jersey, East Brunswick
招募中2 期
18 岁及以上 · 所有性别 · 更新于 2026年9月30日 · NCT07659782A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
- Research Site, New Brunswick
招募中1 期
18 岁及以上 · 所有性别 · 更新于 2026年9月29日 · NCT05877599Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
- Astera Cancer Care /ID# 271915, East Brunswick
招募中1/2 期
18 岁及以上 · 所有性别 · 更新于 2026年9月29日 · NCT06772623Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
- John Theurer Cancer Center at Hackensack UMC, Hackensack
- Morristown Medical Center (MMCORC), Morristown
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月29日 · NCT06881784A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
- Essex Oncology of North Jersey, Belleville
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月28日 · NCT07144280A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
- Hackensack University Medical Center, Hackensack
- Rutgers Cancer Institute of New Jersey, New Brunswick
招募中2 期
18 岁及以上 · 所有性别 · 更新于 2026年9月28日 · NCT05498428A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
- Atlantic Health Morristown Medical Center ( Site 0077), Morristown
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月25日 · NCT06312137A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
- Morristown Medical Center, Morristown
- Rutgers Cancer Institute of New Jersey, New Brunswick
- Overlook Medical Center, Summit
招募中2 期
18 岁及以上 · 所有性别 · 更新于 2026年9月25日 · NCT06667076A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)
- Rutgers Cancer Institute of New Jersey, New Brunswick
招募中2 期
18 岁及以上 · 所有性别 · 更新于 2026年9月25日 · NCT06667908Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
- Hackensack University Medical Center, Hackensack
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack
- John Theurer Cancer Center at JSUMC, Neptune City
招募中1/2 期
18 岁及以上 · 所有性别 · 更新于 2026年9月25日 · NCT07227298A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
- Research Site, Paramus
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月25日 · NCT06868277Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
- Jefferson Health - Cherry Hill, Cherry Hill
- Sidney Kimmel Cancer Center - Washington Township, Sewell
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月24日 · NCT06890598A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
- Local Institution - 0507, Morristown
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月23日 · NCT06561386A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)
- Hackensack University Medical Center, Hackensack
招募中1 期
18 岁及以上 · 所有性别 · 更新于 2026年9月23日 · NCT07140016A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack
招募中1/2 期
18 岁及以上 · 所有性别 · 更新于 2026年9月23日 · NCT06618287Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
- Astera Cancer Care, East Brunswick
- Summit Medical Group PA, Florham Park
- The Valley Hospital - Valley Health System - The Robert and Audrey Luckow Pavilion, Paramus
招募中2/3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月22日 · NCT06712316A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
- Astera Cancer Care /ID# 272359, East Brunswick
- Regional Cancer Care Associates /ID# 270783, Teaneck
招募中2 期
18 岁及以上 · 所有性别 · 更新于 2026年9月22日 · NCT06568939A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
- Hackensack University Medical Center, Hackensack
- Rutgers Cancer Institute of New Jersey, New Brunswick
招募中1/2 期
18 岁及以上 · 所有性别 · 更新于 2026年9月22日 · NCT07488676A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
- Hackensack University Medical Center, Hackensack
招募中1/2 期
18 岁及以上 · 所有性别 · 更新于 2026年9月21日 · NCT07629960A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
- Research Site, Camden
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月18日 · NCT06692738Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
- Clinical Study Site, Mullica Hill
- Clinical Study Site, New Brunswick
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月18日 · NCT06767514A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D Mutation
- Astera Cancer Care, Edison
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月17日 · NCT07566052A Study of Tepotinib and Ivonescimab in People With Non-Small Cell Lung Cancer
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale
招募中1 期
18 岁及以上 · 所有性别 · 更新于 2026年9月16日 · NCT07619339Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
- Astera Cancer Care - East Brunswick, East Brunswick
- John Theurer Cancer Center, Hackensack
- Local Institution - 007-975-A, Somerset
- 以及另外 4 项
招募中2/3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月16日 · NCT04613596Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
- The Valley Hospital - Luckow Pavilion, Paramus
招募中1/2 期
18 岁及以上 · 所有性别 · 更新于 2026年9月16日 · NCT04486833A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
招募中2 期
18 岁及以上 · 所有性别 · 更新于 2026年9月16日 · NCT07323732Using Urine Samples to Identify Lung Cancer
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale
招募中观察性研究欢迎健康志愿者
18 至 90 岁 · 所有性别 · 更新于 2026年9月15日 · NCT06033248FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
- START New Jersey East Brunswick, East Brunswick
招募中1/2 期
18 岁及以上 · 所有性别 · 更新于 2026年9月14日 · NCT06303505ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Astera Cancer Care, East Brunswick
招募中观察性研究
18 岁及以上 · 所有性别 · 更新于 2026年9月14日 · NCT05059444Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
- Hackensack Meridian Health, Hackensack
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
- 以及另外 1 项
招募中2 期
18 岁及以上 · 所有性别 · 更新于 2026年9月11日 · NCT04410796A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC
- Site 104 - START New Jersey, East Brunswick
招募中1 期
18 岁及以上 · 所有性别 · 更新于 2026年9月10日 · NCT07462377A Phase 1/1b Study of IAM1363 in HER2 Cancers
- Rutgers Cancer Institute, New Brunswick
招募中1 期
18 岁及以上 · 所有性别 · 更新于 2026年9月9日 · NCT06253871数据来自 ClinicalTrials.gov，检索日期：2026年10月5日。每项研究自行设定入选标准，由研究团队决定谁能参与。